|
|||||
|
|
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers |
|
| Authors: | Huang Fenglei Koenen-Bergmann Michael Macgregor Thomas R Ring Arne Hattox Susan Robinson Patrick |
| Affiliation: | Department of Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877-0368, USA. fhuang@rdg.boehringer-ingelheim.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |